Table 2.
Donor | S.I. |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
hHSP60 | I | II | III | IV | V | VI | VII | VIII | IX | X | XI | XII | |
EL1 | 7.1 | 2.0 | 2.0 | 3.0 | 1.7 | 1.6 | 3.3 | 2.0 | 1.1 | 3.5 | 1.4 | 1.8 | 3.4 |
EL2 | 2.5 | 0.6 | 0.5 | 0.7 | 1.5 | 1.0 | 0.6 | 0.9 | 1.1 | 1.2 | 2.8 | 1.6 | 3.0 |
EL3 | 3.0 | 1.5 | 1.8 | 1.6 | 2.0 | 9.6 | 4.1 | 4.3 | 5.1 | 2.8 | 1.0 | 1.0 | 1.0 |
EL4 | 2.9 | 1.6 | 5.4 | 2.2 | 1.9 | 1.3 | 3.0 | 2.5 | 4.8 | 4.0 | 2.0 | 1.9 | 5.7 |
EL5 | 2.0 | 1.6 | 1.3 | 1.3 | 2.8 | 3.2 | 1.3 | 1.6 | 1.6 | 2.8 | 3.0 | 1.6 | 2.4 |
EL6 | 2.4 | 2.0 | 1.7 | 1.5 | 1.7 | 1.6 | 0.7 | 0.8 | 1.2 | 0.8 | 0.8 | 3.0 | 2.7 |
EL7 | 3.5 | 1.8 | 1.2 | 1.5 | 1.4 | 0.7 | 1.0 | 3.3 | 1.5 | 1.6 | 1.3 | 1.1 | 1.9 |
T-cell immune response to whole hHSP60 and twelve peptide pools (Roman numerals) is shown for 7 patients with EL. The response was considered positive when S.I. was higher than two and this is shown in bold.